COMMUNIQUÉS West-GlobeNewswire

Genmab Announces EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide Approved by the U.S. Food and Drug Administration for the Treatment of Relapsed or Refractory Follicular Lymphoma
18/11/2025
Company Announcement EPKINLY plus rituximab and lenalidomide (EPKINLY + R 2 ) is the first and only bispecific-based therapy approved by the FDA for follicular lymphoma in the second-line setting In the Phase 3 EPCORE [...]
Comprehensive Healthcare Takes Next Step Toward Expanding Access to Behavioral Healthcare in Central Washington
18/11/2025
Organization selected as one of 10 Certified Community Behavioral Health Clinic (CCBHC) pilot sites in the state YAKIMA, Wash., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Comprehensive Healthcare today announced that it was [...]
Capsa Healthcare to Showcase Integrated Central Fill Automation at ASHP Midyear 2025
18/11/2025
CANAL WINCHESTER, Ohio, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Capsa Healthcare, a leading innovator in medication management and pharmacy automation, will demonstrate its end-to-end pharmacy automation solutions at the 2025 [...]
UPDATE – PrognomiQ Launches ProVue Lung, a Proteomics-Based Laboratory Developed Test to Aid in the Early Detection of Lung Cancer
18/11/2025
– Initial commercial availability begins through an Early Experience Program with Penn Highlands Healthcare and Allegheny Health Network – SAN MATEO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- PrognomiQ , a healthcare [...]
Rad Source Launches RS® 420 Q+ Boost & RS® 420 MAX – High-Capacity Cannabis Decontamination Solutions
18/11/2025
BUFORD, Ga., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Rad Source Technologies, Inc. (Rad Source ® ), the global leader in x-ray-based cannabis decontamination, proudly announces the launch of two advanced systems: RS ® 420 Q+ [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
18/11/2025
Company Announcement COPENHAGEN, Denmark; November 18, 2025 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 32,059 shares as a consequence of the exercise of employee warrants. The increase is effected [...]
Suja Life Announces Confidential Submission of Draft Registration Statement
18/11/2025
OCEANSIDE, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Suja Life, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
18/11/2025
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on November 15, 2025 it granted stock options to purchase 87,297 restricted stock units (RSUs [...]
argenx Announces Results of Extraordinary General Meeting of Shareholders
18/11/2025
November 18, 2025 – 10:01 PM C ET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, [...]
Genmab Announces Pricing of Private Offering of Senior Secured Notes and Senior Unsecured Notes and Completion of Syndication of New Senior Secured Term Loan Facility
18/11/2025
Media Release COPENHAGEN, Denmark; November 18, 2025 Genmab A/S (Nasdaq: GMAB) (“Genmab”) announced today that it and its wholly owned subsidiary Genmab Finance LLC (“Genmab Finance”) have priced their previously [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
18/11/2025
ZUG, Switzerland, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The attached notification relates to the purchase of ordinary shares by a member of the Company’s Board of Directors. Attachment notification-of-managers-transaction- [...]
Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
18/11/2025
IRVINE, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced preliminary results from an investigator-initiated trial conducted at the University of Chicago [...]
Neurona Therapeutics Appoints Dr. Eduardo Dunayevich as Chief Medical Officer
18/11/2025
SAN FRANCISCO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Neurona Therapeutics , a clinical-stage biotherapeutics company focused on advancing regenerative cell therapies for disorders of the nervous system, today announced the [...]
Solana Company Reports Third Quarter 2025 Financial Results
18/11/2025
NEWTOWN, Pa., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Solana Company (NASDAQ: HSDT) (the “Company” or “HSDT”), a publicly listed company that has expanded its business to include a digital asset treasury (“DAT”) dedicated to [...]
BBOT to Participate in Upcoming December Investor Healthcare Conferences
18/11/2025
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today [...]
SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025
18/11/2025
SANTA CLARA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the [...]
Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
18/11/2025
Renowned urologist Dr. Mark Hong sets new global benchmark for urologist-led, MRI-guided prostate treatment, leading a growing movement toward incision-free prostate therapy TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- [...]
Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations on Wednesday, November 19, 2025
18/11/2025
NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced it will [...]
Olema Oncology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
18/11/2025
SAN FRANCISCO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and [...]

Pages